Harvard Bioscience (HBIO) vs Quanterix (QTRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Harvard Bioscience (HBIO) has outperformed Quanterix (QTRX) over the past year, gaining 84.8% versus a loss of 46.5%. Over five years, HBIO leads with a -88.1% price change compared with -93.8% for QTRX. Quanterix is the larger company by market cap ($151.8 million vs $37.0 million), about 4.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HBIO | QTRX |
|---|---|---|
| Share price | $8.13 | $3.21 |
| Market cap | $37.01M | $151.81M |
| 1-day change | -4.35% | -3.46% |
| YTD return | +21.34% | -49.53% |
| 1-year return | +84.77% | -46.50% |
| 5-year return | -88.11% | -93.79% |
| Forward P/E | 12.60 | — |
| EPS (TTM) | $-2.31 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.40 | $8.77 |
| 52-week low | $3.80 | $2.15 |
| Distance from 52-week high | -13.51% | -63.40% |
| Analyst consensus | none | none |
| Avg. price target upside | -7.75% | -6.54% |
| Average volume | 17.98K | 762.14K |
| Shares outstanding | 4.55M | 47.29M |
| Employees | 316 | 450 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Quanterix is about 4.1 times larger than Harvard Bioscience by market value ($151.81M vs $37.01M).
- HBIO has outperformed QTRX by 131.3 percentage points over the past year.
About Harvard Bioscience
HBIO stock →Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 316 employees
About Quanterix
QTRX stock →Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
Industrials · Biotechnology: Laboratory Analytical Instruments · 450 employees
HBIO vs QTRX FAQ
Which is bigger, Harvard Bioscience or Quanterix?
Quanterix (QTRX) is larger, with a market capitalization of $151.81M compared with $37.01M for Harvard Bioscience (HBIO).
Which stock has performed better over the past year, HBIO or QTRX?
HBIO returned +84.77% over the past 12 months, compared with -46.50% for QTRX (price return, excluding dividends). Past performance does not predict future results.
Are Harvard Bioscience and Quanterix in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.